Oxyntomodulin
Oxyntomodulin from HG Wellness Peptides is a dual-action peptide that engages GLP-1 and glucagon receptor pathways, making it valuable for metabolic signaling research. It is frequently selected for in-vitro or preclinical models examining appetite-related signaling mechanisms, thermogenic signaling pathways, glucose-related signaling mechanisms, and gut hormone signaling.
Our Oxyntomodulin is synthesized using solid-phase techniques in GMP-compliant U.S. facilities, then purified and characterized by independent HPLC and mass spectrometry. Each batch is assigned a distinct lot number with a corresponding Certificate of Analysis, providing clear, auditable documentation of purity and identity.
Supplied in lyophilized form, the peptide is designed for reliable storage and reconstitution under researcher-defined buffer conditions.
All Oxyntomodulin offered by us is designated for Research Use Only and may not be used for human or veterinary purposes.
Disclaimer
All products offered by HG Wellness Peptides are strictly intended for laboratory, scientific, and research purposes only. They are NOT for human consumption, clinical use, veterinary application, diagnostic procedures, or direct administration of any kind.
None of the statements on this website have been evaluated or approved by the U.S. Food and Drug Administration (FDA). These products are not medical devices, supplements, or drugs, and are not intended to diagnose, treat, cure, or prevent any disease, condition, or physical ailment.
By purchasing from this website, the buyer acknowledges and agrees that they are at least 21 years of age and are fully qualified, trained, and equipped to handle research chemicals in accordance with applicable laws, health, and safety protocols. HG Wellness Peptides assumes no liability for any direct, indirect, or consequential damages resulting from improper handling, misuse, or unauthorized application of these products.
Reach Out Anytime
Send questions about peptides, orders, or documentation, and our team responds promptly with clear, evidence-based guidance.